×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Kidney Stones Market

ID: MRFR/HC/51106-HCR
200 Pages
Garvit Vyas
October 2025

India Kidney Stones Market Research Report: By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) andBy Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Kidney Stones Market Infographic
Purchase Options

India Kidney Stones Market Summary

As per analysis, the India Kidney Stones Market size was estimated at 118.8 USD Million in 2024. The Kidney Stones market is projected to grow from 124.84 USD Million in 2025 to 205.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The India kidney stones market is experiencing notable growth driven by increasing awareness and technological advancements.

  • The market is witnessing a rising incidence of kidney stones, indicating a growing health concern among the population.
  • Technological advancements in treatment options are enhancing patient outcomes and driving market growth.
  • Increased awareness and preventive measures are contributing to a shift towards proactive healthcare management.
  • The growing prevalence of risk factors and advancements in medical technology are key drivers of the market's expansion.

Market Size & Forecast

2024 Market Size 118.8 (USD Million)
2035 Market Size 205.0 (USD Million)
CAGR (2025 - 2035) 5.08%

Major Players

Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Stryker (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

India Kidney Stones Market Trends

currently experiencing notable developments in the India Kidney Stones Market., driven by a combination of increasing prevalence and advancements in treatment options. The rising incidence of kidney stones in the population appears to be influenced by dietary habits, lifestyle changes, and environmental factors. As awareness grows regarding the importance of hydration and dietary management, individuals are more inclined to seek preventive measures. This shift in consumer behavior is likely to foster demand for innovative solutions, including dietary supplements and advanced medical devices designed to facilitate the management of kidney stones. Moreover, the healthcare sector is witnessing a surge in technological advancements that enhance diagnostic and treatment capabilities. Minimally invasive procedures and improved imaging techniques are becoming more prevalent, which may lead to better patient outcomes and increased satisfaction. The integration of telemedicine in consultations and follow-ups also seems to be gaining traction, providing patients with convenient access to healthcare professionals. As these trends continue to evolve, the kidney stones market is poised for growth, reflecting a broader commitment to improving patient care and outcomes in the management of this condition.

Rising Incidence of Kidney Stones

The prevalence of kidney stones is on the rise, attributed to various factors such as dietary changes and lifestyle choices. This trend indicates a growing need for effective management solutions, prompting healthcare providers to focus on preventive strategies and treatment options.

Technological Advancements in Treatment

Innovations in medical technology are transforming treatment approaches within the kidney stones market. Minimally invasive techniques and enhanced imaging methods are becoming standard, potentially improving patient experiences and outcomes.

Increased Awareness and Preventive Measures

There is a noticeable increase in public awareness regarding kidney stones, leading to a greater emphasis on preventive measures. Educational initiatives and health campaigns are encouraging individuals to adopt healthier lifestyles, which may contribute to a decline in incidence rates.

India Kidney Stones Market Drivers

Rising Healthcare Expenditure

In India, the increase in healthcare expenditure is a significant driver for the kidney stones market. With the government and private sectors investing more in healthcare infrastructure, access to quality medical services is improving. The healthcare expenditure as a percentage of GDP has risen to approximately 3.5%, reflecting a growing commitment to health services. This increase allows for better diagnostic tools and treatment options for kidney stones, making it easier for patients to receive timely care. As healthcare spending continues to rise, the kidney stones market is expected to benefit from enhanced service delivery and improved patient outcomes.

Increase in Geriatric Population

The increase in the geriatric population in India is another critical driver for the kidney stones market. As the population ages, the incidence of kidney stones tends to rise due to various age-related factors, including decreased kidney function and changes in dietary habits. Currently, around 8% of the Indian population is aged 60 and above, and this demographic is expected to grow significantly in the coming years. This trend suggests a potential increase in the demand for kidney stone treatments and management solutions. Consequently, the kidney stones market is likely to expand to accommodate the needs of this aging population.

Advancements in Medical Technology

Technological innovations in the medical field are playing a crucial role in shaping the kidney stones market in India. The introduction of minimally invasive procedures, such as laser lithotripsy and ureteroscopy, has revolutionized treatment options for patients. These advancements not only reduce recovery time but also minimize complications associated with traditional surgical methods. The market for kidney stone treatment devices is projected to grow at a CAGR of 8% over the next five years, indicating a robust demand for advanced medical technologies. As healthcare providers adopt these innovative solutions, the kidney stones market is likely to expand, catering to a growing patient population.

Growing Awareness of Kidney Health

The kidney stones market in India is also influenced by the growing awareness of kidney health among the population. Public health campaigns and educational initiatives are increasingly focusing on the prevention and management of kidney stones. As awareness rises, individuals are more likely to seek medical advice and treatment, leading to an uptick in market demand. Reports indicate that awareness programs have led to a 20% increase in consultations for kidney-related issues over the past year. This heightened awareness is likely to drive growth in the kidney stones market as more people prioritize their kidney health and seek preventive measures.

Growing Prevalence of Risk Factors

The kidney stones market in India is experiencing growth due to the increasing prevalence of risk factors associated with kidney stones. Factors such as obesity, diabetes, and dietary habits contribute significantly to the incidence of kidney stones. According to recent studies, approximately 12% of the Indian population is affected by obesity, which is a major risk factor for stone formation. Additionally, the consumption of high-sodium and high-oxalate foods is prevalent in urban areas, further exacerbating the situation. This rise in risk factors is likely to drive demand for treatment options in the kidney stones market, as more individuals seek medical intervention to manage their conditions.

Market Segment Insights

By Type: Calcium Oxalate Stones (Largest) vs. Uric Acid (Fastest-Growing)

In the India kidney stones market, Calcium Oxalate Stones hold the largest share owing to their prevalence among patients. They are often associated with dietary factors and conditions that lead to increased oxalate levels in the urine. Uric Acid stones, while smaller in market share, are rapidly becoming a significant concern due to lifestyle changes and dietary habits that promote their formation, leading to a noteworthy shift in the compositional landscape of kidney stone types. The growth trends in this segment indicate a rising incidence of Uric Acid stones, driven by urbanization, dietary modifications, and increased awareness among healthcare professionals regarding kidney stone management. The growing prevalence of obesity and metabolic disorders further contributes to the emergent nature of Uric Acid stones. Meanwhile, the established nature of Calcium Oxalate Stones highlights the need for ongoing preventive strategies and treatment efficacy evaluations in the market.

Calcium Oxalate Stones (Dominant) vs. Uric Acid (Emerging)

Calcium Oxalate Stones remain the dominant type in the segment, characterized by their formation from calcium and oxalate, which can arise from excessive intake of certain foods high in oxalates, like spinach and nuts. Their commonality makes them a critical focus for treatment modalities and preventive measures. In contrast, Uric Acid stones are emerging as a significant type in the India kidney stones market due to increased uric acid levels, often linked to high-protein diets and metabolic syndromes. The emergence of Uric Acid stones presents a new challenge for healthcare providers, emphasizing the need for tailored dietary interventions and focused treatment strategies to address the shifting dynamics in kidney stone types.

By Treatment Type: Extracorporeal Shock Wave Lithotripsy (Largest) vs. Ureteroscopy (Fastest-Growing)

In the India kidney stones market, treatment types like Extracorporeal Shock Wave Lithotripsy (ESWL), Ureteroscopy, Medications, and Percutaneous Nephrolithotomy (PCNL) exhibit varied market share distributions. Currently, ESWL holds the largest share due to its high efficacy and non-invasiveness, preferred by many patients and healthcare providers. Ureteroscopy, while smaller in share, is rapidly gaining traction owing to advancements in technology and procedural success rates, resulting in a shift in preferences among practitioners. Growth trends in this segment are predominantly driven by the rising incidence of kidney stones and increasing awareness of treatment options. The shift towards minimally invasive procedures is also contributing to the growth of Ureteroscopy as a faster treatment alternative. As healthcare infrastructure improves and technological innovations emerge, both ESWL and Ureteroscopy are positioned to drive enhanced patient outcomes and satisfaction in the upcoming years.

Extracorporeal Shock Wave Lithotripsy (Dominant) vs. Ureteroscopy (Emerging)

Extracorporeal Shock Wave Lithotripsy (ESWL) stands out as the dominant treatment option, favored for its non-invasive nature and effectiveness in fragmenting kidney stones without the need for surgical intervention. This method is particularly advantageous for patients seeking quicker recovery and less postoperative discomfort. In contrast, Ureteroscopy is emerging as a vital option due to its ability to treat a broader range of stone sizes and locations. As technology advances, Ureteroscopy's efficacy improves, positioning it as a compelling choice for those requiring immediate relief. Both treatment methods demonstrate unique advantages that cater to varying patient needs, with ESWL primarily appealing to those preferring non-invasive treatments, while Ureteroscopy attracts patients needing more targeted interventions.

By Diagnosis: CT Scan (Largest) vs. Ultrasound (Fastest-Growing)

In the India kidney stones market, the diagnosis segment is characterized by varying technologies, each with its unique contribution to the market share. CT Scan emerges as the largest segment, significantly leading the market due to its accuracy and efficiency in diagnosing kidney stones. Following CT Scan, Ultrasound is gaining traction, driven by its non-invasive nature and accessibility, catering to a wider patient base. Intravenous Pyelography and X-Ray hold a smaller share but remain relevant for specific diagnostic scenarios. The growth trends in this segment are shaped by technological advancements and increasing awareness about kidney stone conditions. The demand for non-invasive and painless diagnostic methods is propelling the popularity of Ultrasound, which is now seen as the fastest-growing modality. Simultaneously, CT Scan maintains its dominance due to enhanced imaging capabilities, leading to quicker and more accurate diagnoses. This dynamic is reflective of the broader trends towards patient-centric healthcare solutions and the rising prevalence of kidney stone cases across various demographics.

CT Scan (Dominant) vs. Ultrasound (Emerging)

CT Scan is the dominant diagnostic technique in the kidney stones segment due to its unmatched sensitivity and specificity, allowing for precise localization of stones, which aids in treatment planning. It is favored by healthcare providers for its rapid assessment capabilities. In contrast, Ultrasound is emerging as a preferred choice in recent years, primarily due to its non-invasive approach and lack of ionizing radiation, making it suitable for repeated use, especially in vulnerable populations. The growing preference for Ultrasound reflects a shift towards safer diagnostic practices, alongside it expanding accessibility in rural and urban healthcare settings. Both modalities complement each other, with CT Scan retaining its role in complex cases while Ultrasound captures the growing need for patient-friendly solutions.

Get more detailed insights about India Kidney Stones Market

Key Players and Competitive Insights

The kidney stones market in India is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Boston Scientific (US), Medtronic (US), and Johnson & Johnson (US) are actively enhancing their market presence through various strategic initiatives. For instance, Boston Scientific (US) has focused on expanding its product portfolio, particularly in minimally invasive technologies, which aligns with the growing demand for less invasive treatment options. This strategic positioning not only enhances their competitive edge but also addresses the evolving needs of healthcare providers and patients alike.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like C.R. Bard (US) and Cook Medical (US) is significant, as they leverage their established reputations and extensive distribution networks to maintain a competitive advantage.

In October Medtronic (US) announced a strategic partnership with a leading Indian healthcare provider to enhance access to its advanced kidney stone management technologies. This collaboration is expected to facilitate the introduction of innovative treatment solutions tailored to the local market, thereby expanding Medtronic's footprint in India. Such partnerships are crucial as they not only enhance product availability but also foster trust among healthcare professionals and patients.

In September Johnson & Johnson (US) launched a new line of ureteral stents designed specifically for the Indian market, emphasizing patient comfort and ease of use. This product introduction reflects the company's commitment to addressing local healthcare challenges and demonstrates a proactive approach to market needs. By focusing on patient-centric innovations, Johnson & Johnson is likely to strengthen its market position and enhance customer loyalty.Moreover, in August 2025, C.R. Bard (US) expanded its manufacturing capabilities in India, aiming to increase production efficiency and meet the rising demand for kidney stone treatment devices. This move not only signifies a commitment to the Indian market but also positions C.R. Bard to respond swiftly to market fluctuations and customer needs. Such operational enhancements are vital in a market where timely access to medical devices can significantly impact patient outcomes.

As of November current trends in the kidney stones market indicate a shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and responsiveness in a rapidly changing healthcare environment.

Key Companies in the India Kidney Stones Market include

Industry Developments

Recent developments in the India Kidney Stones Market indicate a surge in healthcare services focused on urology, with institutions like Manipal Hospitals and Apollo Hospitals enhancing their treatment offerings. Notably, in April 2023, Medanta announced the launch of a specialized kidney stone treatment program, integrating advanced laser technology for effective dissolution.

Current affairs highlight a growing awareness of preventive measures, with campaigns promoting hydration and dietary management, pivotal in addressing kidney stone prevalence, which affects approximately 12-15% of the Indian population. In the last two years, Fortis Healthcare introduced new minimally invasive surgical techniques in July 2022, increasing patient accessibility to advanced care.

There have been no major mergers or acquisitions reported among the specified companies in this sector recently, indicating a focus on internal growth rather than consolidation. The market valuation for hospitals involved in kidney stone treatment continues to rise, reflecting enhanced patient engagement and new technological innovations.

Companies like Wockhardt Hospitals and Narayana Health are experiencing growth in patient footfall and revenue streams, driven by the increasing incidence of kidney stones and the establishment of specialized treatment centers.

India Kidney Stones Market Segmentation Insights

Kidney Stones Market Type Outlook

  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

Kidney Stones Market Treatment Type Outlook

  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

Kidney Stones Market Diagnosis Outlook

  • Ultrasound
  • Intravenous Pyelography
  • CT scan
  • X-Ray
  • Others

Future Outlook

India Kidney Stones Market Future Outlook

The Kidney Stones Market in India is projected to grow at a 5.08% CAGR from 2025 to 2035, driven by increasing prevalence, advancements in treatment technologies, and rising healthcare expenditure.

New opportunities lie in:

  • Development of telehealth platforms for remote consultations and follow-ups.
  • Investment in AI-driven diagnostic tools for early detection of kidney stones.
  • Expansion of outpatient surgical centers to enhance patient access and reduce costs.

By 2035, the kidney stones market is expected to exhibit robust growth and increased accessibility.

Market Segmentation

India Kidney Stones Market Type Outlook

  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

India Kidney Stones Market Diagnosis Outlook

  • Ultrasound
  • Intravenous Pyelography
  • CT Scan
  • X-Ray
  • Others

India Kidney Stones Market Treatment Type Outlook

  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

Report Scope

MARKET SIZE 2024 118.8(USD Million)
MARKET SIZE 2025 124.84(USD Million)
MARKET SIZE 2035 205.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.08% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Stryker (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP)
Segments Covered Type, Treatment Type, Diagnosis
Key Market Opportunities Advancements in minimally invasive treatment technologies enhance patient outcomes in the kidney stones market.
Key Market Dynamics Rising prevalence of kidney stones drives demand for advanced treatment options and innovative technologies in the market.
Countries Covered India
Leave a Comment

FAQs

What is the projected market value of the India Kidney Stones Market in 2024?

The India Kidney Stones Market is expected to be valued at 144.0 USD Million in 2024.

What is the expected market value of the India Kidney Stones Market by 2035?

By 2035, the market is anticipated to reach a value of 300.0 USD Million.

What is the expected CAGR for the India Kidney Stones Market from 2025 to 2035?

The expected compound annual growth rate (CAGR) for the market is 6.9% from 2025 to 2035.

Which type of kidney stone is expected to dominate the market in terms of value in 2024?

In 2024, Calcium Oxalate Stones are projected to dominate the market with a value of 57.6 USD Million.

What market value is estimated for Uric Acid stones in 2024 within India’s Kidney Stones Market?

The market value for Uric Acid stones is estimated at 36.0 USD Million in 2024.

Who are the key players in the India Kidney Stones Market?

Major players include Manipal Hospitals, Max Healthcare, and Apollo Hospitals among others.

What challenges might the India Kidney Stones Market face in the coming years?

Challenges may include increasing healthcare costs and limited access to specialized medical facilities.

How much is the market for Struvite Kidney Stones expected to grow by 2035?

The market for Struvite Kidney Stones is expected to reach 50.0 USD Million by 2035.

What are the expected market values for Cystine Stones in 2024 and 2035?

Cystine Stones are expected to be valued at 16.8 USD Million in 2024 and 35.0 USD Million by 2035.

What opportunities exist for growth in the India Kidney Stones Market?

Opportunities for growth may include advancements in medical technology and increased public awareness regarding kidney health.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions